Neoplasia/BPH

	Preoperative predictors about lymph node metastasis and biochemical recurrence in high-risk prostate cancer patients: a clinic pathological retrospective study. BMC Urol Wang C, Wang G, Xiao L, Du H, Xu Y, Li S, Yang X. PMID: 41350993 [PubMed - as supplied by publisher]
	Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA PET-CT Reports. Mol Imaging Biol Ismayilov R, Aktas A, Gencoglu EA, Oguz A, Altundag O, Akcali Z. PMID: 41350971 [PubMed - as supplied by publisher]
	Infection risks and biopsy-associated complications in prostate cancer diagnosis: a review of recent literatures. Prostate Cancer Prostatic Dis Nikolaevich PV, Samuel AO, Fayazovich UM, Olaiya VO, Adesegun FA. PMID: 41350942 [PubMed - as supplied by publisher]
	Comparison of Retzius-sparing versus anterior robotic-assisted radical prostatectomy in patients with prior transurethral resection of the prostate (TURP). World J Urol Schütz V, Hatiboglu G, Würkner D, Tekesin M, Feisst M, Duensing S, Huber J, Hohenfellner M, Kaufmann B. PMID: 41350773 [PubMed - indexed for MEDLINE]
	Prostate Cancer: Current Status of Novel Molecular Imaging and Future Prospects. Eur Urol Focus Wunsch DC 3rd, Turkbey B. PMID: 41350193 [PubMed - as supplied by publisher]
	Pituitary Metastasis from Renal Cell Carcinoma: Case Report, Systematic Review, and Worldwide Distribution Analysis. Neurocirugia (Engl Ed) García-Nájera AR, Vásquez-Rafael C, Benítez-Rodríguez FJ, García-Nájera O, Gamboa-Jiménez TI, Martínez-Pineda W, Vergara-Juárez J, Armas-Salazar A, Carrillo-Ruiz JD, Jiménez-Ponce F, Beltrán JQ. PMID: 41349924 [PubMed - as supplied by publisher]
	Immune checkpoint inhibition in renal cell carcinoma: Mechanisms of resistance and emerging therapeutic strategies. Biomed Pharmacother Darzi A, Shokouhfar M, Farajee N, Ghafari A, Deldar F, Eini P, Vanan AG, Bahrami N. PMID: 41349248 [PubMed - as supplied by publisher]
	Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints. J Urol Shore ND, De Giorgi U, Tutrone RF, Bailen JL, Roos EP, Kliment J, Marx G, Karsh LI, Ramirez-Backhaus M, Uchio EM, Supiot S, Tang Y, Rosbrook B, Haas GP, Rosales M, Zohren F, Tarazi J, Freedland SJ. PMID: 41349040 [PubMed - as supplied by publisher]
	Efficacy and Reliability of Mobile Uroflowmetry in Patients With Benign Prostatic Hyperplasia Undergoing Transurethral Resection: Prospective Multicenter Observational Pilot Validation Study. J Med Internet Res Song SH, Chung Y, Ryu H, Lee JW, Lee S. PMID: 41349029 [PubMed - indexed for MEDLINE]
	Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment. PLoS One Frey LJ, Banasiewicz KE, Ruckes C, Wagner I, Haack M, Mager R, Juengel E, Haferkamp A, Duwe G, Brandt MP. PMID: 41348715 [PubMed - indexed for MEDLINE]
	A panel of plasma proteins associated with venous thromboembolism in patients with prostate cancer. Cancer Biomark Jose A, Lu S, Zhang C, La J, Young M, Gaziano JM, Fillmore NR, Ravid K, Chitalia VC. PMID: 41348521 [PubMed - indexed for MEDLINE]
	ZSTK474 suppresses bladder cancer cell migration and invasion via PI3K/Akt/Girdin pathway: an in vitro study. Int Urol Nephrol Song Z, Wang Y, Yu C, Sha K, Zhao M, Liu T. PMID: 41348302 [PubMed - as supplied by publisher]
	Zero-Shot PI-RADS Version 2.1 Scoring with ChatGPT-4 Turbo and Llama 3: Diagnostic Performance and Agreement with Abdominal Radiologists. Radiol Imaging Cancer Firoozeh N, Mastrodicasa D, Behr S, Muglia VF, Westphalen AC. PMID: 41347921 [PubMed - indexed for MEDLINE]
	Emerging biomarkers in prostate cancer diagnosis and treatment: Insights into genetic, RNA and metabolic markers (Review). Int J Oncol Huang Y, Mao J, Li X. PMID: 41347816 [PubMed - indexed for MEDLINE]
	Tumors and tumor-like lesions of the gall bladder-A review. Indian J Pathol Microbiol Husain N, Shukla S, Srivastava P. PMID: 41347612 [PubMed - indexed for MEDLINE]
	Renoprotective properties of resveratrol in the treatment of renal fibrosis, renal cell carcinoma, diabetic nephropathy and nephrotoxicity: a review of current evidence based on underlying cellular mechanisms. Toxicol Mech Methods AlRamadneh TN, Abdulsahib WK, Ismael SH, Roopashree R, Mohanty B, Nandhini SU, Arora V, Chauhan AS, Farhood B. PMID: 41347316 [PubMed - as supplied by publisher]
	G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. Front Cell Dev Biol Xiong W, Zhou B, Shi J, Ni D, Xiong Z. PMID: 41347146 [PubMed]
	Prognostic factors for overall survival in patients with metastatic castration-resistant prostate cancer treated with radium-223: a meta-analysis of real-world evidence. Front Oncol Song B, Shao H, He Y, Zhu X, Qin P. PMID: 41347095 [PubMed]
	Diagnostic accuracy of PSA derivatives for prostate cancer in patients with low prostate-specific antigen levels. Front Oncol Kadeer A, Maolake A, Aimaier A, Abuduwaili M, Ni Z, Li J. PMID: 41347082 [PubMed]
	Diagnostic Pitfall of Lytic Bone Lesions: A Case of Chromophobe Renal Cell Carcinoma Coexisting With Multiple Myeloma. Cureus Almutairi AM, Abusedera O, Shaheen AM Sr. PMID: 41346886 [PubMed]

Articles 1 - 20 / 183680

Page 1 of 9184



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy